Predict your next investment

Emulate company logo
Corporation
HEALTHCARE | Biotechnology
emulatebio.com

See what CB Insights has to offer

Founded Year

2014

Stage

Series E | Alive

Total Raised

$227.17M

Last Raised

$82M | 2 mos ago

About Emulate

Emulate focuses on commercializing Organs-on-Chips as an automated, human bio-emulation platform that achieves a new standard for mimicking human physiology so that responses to medicines, chemicals, and diseases can be accurately predicted.

Emulate Headquarter Location

27 Drydock Avenue 5th Floor

Boston, Massachusetts, 02210,

United States

617-704-9222

Latest Emulate News

StartUPDATES: New developments from healthcare startups

Sep 10, 2021

MedCity News Check out new developments from Emulate, HealthMine, LuminDx, and more. Shares0 Emulate this week announced the close of an $82 million Series E financing round led by existing investor Northpond Ventures with additional participation from Perceptive Advisors. With this investment, Emulate has raised nearly $225 million to date. “This fundraise is a testament to the fact that Emulate organ-chips are allowing the exploration of human biology like never before,” said Jim Corbett, CEO of Emulate. “Over the last year, we have bolstered our leadership team, accelerated product development goals, and seen healthy growth in demand for our products. Several leading indicators validate our belief that organ-on-a-chip technology will dramatically transform the entire drug discovery and development pipeline and ultimately eliminate unnecessary animal testing.” HealthMine  published a timely article sharing how health plans can leverage digital technology to effectively communicate with members about well-child visits and immunizations to ensure children stay on track for healthy growth and development coming out of the pandemic. Read the full article to learn more about prioritizing prevention and incentivizing parents and caregivers to get the right care for their children using digital engagement and rewards & incentives. Health Wildcatters , a Dallas-based seed accelerator, added 10 startups with its latest cohort. They include: A LaRue Company (Winston-Salem, NC) – the designer of the LaRue Surgical Evacuator and  Clean Removal Process to aid surgeons in providing patients a safe, rapid, less invasive  procedure for removing gelatinous and similar materials from the body or surgical site. Aliform (Aachen, Germany) – which develops minimally invasive surgical devices for treating skin conditions. AllergenIQ (Southlake, TX)– a telemedicine platform that provides comprehensive integrative care, support, and treatment for children who have allergic conditions including food allergies. Birkeland Current – SOVRINTI (Waco, TX) – Changing the future of independent aging and  home-based care by scaling senior functional assessment to support earlier clinical diagnosis,  person-centered home care, and timely care interventions. Oral Genome (Carlsbad, CA) – develops personalized insights about oral health and recommended preventative measures based on saliva samples. Parrots Inc. (Seattle, WA) – Creator of “Polly”, an inclusive platform using AI and machine  learning to give a smart voice and telecare to people with neurological disorders. RECORNEA (Udine, Italy) – is a pre-clinical stage medtech ophthalmic company developing therapeutic corneal implants. Lung Healing Technologies, Inc. (Winnetka, IL) – Its SmartDrain is designed to monitor CO2, O2, and pressure in a chest drain to reduce hospitalization costs by over $4k per patient or $1B per  year in the US alone. Spectryx (Palo Alto, CA) – seeks to transform the drug development industry with high-throughput, label-free, ultra-sensitive automated sensors. Sympal (Boston, MA) – Clear aligner company disrupting the orthodontic industry. LuminDx, a digital health company developing a smartphone app to help healthcare clinicians quickly and accurately identify skin conditions with the help of AI, has changed its name to Piction Health . The name change reflects how the company helps physicians and other clinicians identify and act regarding skin conditions through its AI application that recognizes conditions by uploading a picture. Optimize Health , a remote patient monitoring tech company, has announced that Todd Haedrich will serve as the company’s new CEO. Co-founder and former CEO Jeff LeBrun will step into a new role as chief strategy officer, while also retaining his position as executive board chairman. Haedrich previously worked at Covetrus where he served as the company’s Global Technology Services chief commercial officer. He has also held roles at athenahealth.

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Emulate

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Emulate is included in 6 Expert Collections, including Pharma Startups.

P

Pharma Startups

6,549 items

Pharmaceutical companies working across drug discovery, drug development and drug manufacturing.

C

Clinical Trials Tech

317 items

Companies developing products and services to streamline drug R&D, from drug discovery, pre-clinical testing, and clinical trials.

F

Future of Pharma R&D

62 items

D

Digital Health 150 (2019)

150 items

2019's cohort of the most promising digital health startups transforming the healthcare industry

B

Biopharmaceuticals

5,881 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

R

Regenerative Medicine

1,767 items

Regenerative medicine refers to the process of activating, replacing, engineering or regenerating human genetic material, cells, tissues or organs to restore normal function. It also includes bioengineered tissues used for in vitro testing (e.g. organ-on-a-chip, organoids).

Emulate Patents

Emulate has filed 77 patents.

The 3 most popular patent topics include:

  • Biotechnology
  • Fluid dynamics
  • Clusters of differentiation
patents chart

Application Date

Grant Date

Title

Related Topics

Status

7/12/2017

10/19/2021

Coagulation system, Blood tests, Coagulopathies, Anticoagulants, Fluid dynamics

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

7/12/2017

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Grant Date

10/19/2021

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Title

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Related Topics

Coagulation system, Blood tests, Coagulopathies, Anticoagulants, Fluid dynamics

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Grant

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Emulate Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Emulate Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.